Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsMedical Oncology & ChemotherapyCardio-Oncology Protocols: Monitoring Anthracycline & Trastuzumab Left Ventricular Ejection Fraction (LVEF) Strain
Medical Oncology & Chemotherapy

Cardio-Oncology Protocols: Monitoring Anthracycline & Trastuzumab Left Ventricular Ejection Fraction (LVEF) Strain

10 min read
Sep 4, 2026
Spica Healthcare Clinical & Surgical Protocol Illustration #124

Clinical Summary & Key Takeaways

A vital interdisciplinary clinical cardio-oncology guide on preventing and managing Cancer Therapy-Related Cardiac Dysfunction (CTRCD), evaluating cumulative Doxorubicin thresholds, Trastuzumab/Pertuzumab HER2 monitoring, Global Longitudinal Strain (GLS) echocardiography, and cardioprotective Dexrazoxane/ACE-inhibitor protocols.

CRITICAL CLINICAL RED FLAG: Any oncology patient receiving anthracyclines or anti-HER2 therapy who develops progressive shortness of breath on exertion, orthopnea (breathlessness lying flat), unexplained dry cough, or bilateral ankle swelling requires emergency echocardiography and serum NT-proBNP measurement.

1. Types of Cancer Therapy-Related Cardiac Dysfunction (CTRCD)

Cardiotoxicity from systemic cancer treatments is broadly divided into two distinct pathophysiological categories:

  • Type I (Anthracycline-Induced): Doxorubicin/Epirubicin cause dose-dependent, irreversible myocyte necrosis through Topoisomerase II-beta inhibition and reactive oxygen species generation (cumulative dose limit: Doxorubicin <=400–450 mg/m²).

  • Type II (Anti-HER2 Induced): Trastuzumab (Herceptin) / Pertuzumab block HER2 signaling in cardiomyocytes, causing dose-independent, largely reversible contractile stunning.

2. Advanced Diagnostic Surveillance: GLS & Biomarkers

Standardized surveillance schedule throughout treatment:

  1. Baseline Comprehensive Echocardiogram: Measurement of 3D LVEF, Global Longitudinal Strain (GLS), and diastolic filling pressures.

  2. Subclinical Cardiotoxicity Threshold: A relative drop in GLS of >15% from baseline (even with normal LVEF) indicates early cardiomyocyte stress.

  3. Serum Cardiac Biomarkers: Serial High-Sensitivity Troponin I (hs-cTnI) and NT-proBNP monitored before each cycle.

"Curing cancer should never come at the cost of a damaged heart. Baseline cardiovascular risk stratification and proactive GLS strain monitoring ensure safe completion of every curative oncology cycle." — Dr. Neha Gupta
Spica Healthcare Clinical & Surgical Protocol Illustration #124
Spica Healthcare Clinical & Surgical Protocol Illustration #124

3. Cardioprotective Pharmacotherapy: ACE-Inhibitors & Beta-Blockers

Initiating early cardioprotection with Enalapril/Ramipril and Carvedilol/Bisoprolol upon detecting subclinical GLS decline prevents irreversible LVEF drop and allows uninterrupted completion of cancer chemotherapy.

CLINICAL CAUTION: Relying solely on 2D Left Ventricular Ejection Fraction (LVEF) misses subclinical myocardial injury; 2D Speckle Tracking Global Longitudinal Strain (GLS) is mandatory for early detection of cardiotoxicity.

4. Dexrazoxane in High Cumulative Anthracycline Dosing

Dexrazoxane (an iron-chelating Topoisomerase II-beta inhibitor) is administered 30 minutes prior to Doxorubicin in high-risk patients to prevent free-radical myocardial damage.

5. Peer-Reviewed References & Clinical Guidelines

1. 2022 ESC Guidelines on Cardio-Oncology: European Society of Cardiology Clinical Practice Framework — European Heart Journal, 2022; 43(41): 4229-4361.

2. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancer: ASCO Guideline — J Clin Oncol, 2021; 39(9): 1020-1040.

Frequently Asked Patient Questions

Limb Salvage with modular titanium megaprosthesis removes the tumor completely while preserving the limb, allowing patients to walk, work, and maintain full social independence without the physical disability of an artificial limb.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Senior Consultant & Clinical Director — Medical Oncology

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.